STAT-Dx
company
About
STAT-Dx is focused on the development of near-patient testing products for healthcare professionals.
- Barcelona,Catalonia,Spain
- 11 - 50
- https://www.stat-dx.com
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- €2M
- Industries
- Biotechnology,Health Care,Health Diagnostics
- Founded date
- Jan 1, 2010
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- STAT-Dx Life S.L.
- Also Known As
- STAT-Diagnostica
STAT-Diagnostica focuses in the development of near-patient testing products for healthcare professionals, mainly for short turnaround time applications and critical care.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
€49.10M
STAT-Dx has raised a total of
€49.10M
in funding over 2 rounds. Their latest funding was raised on
Apr 10, 2016 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 10, 2016 | Series C | €25M | 8 |
|
— | Detail |
| May 6, 2013 | Series B | €22.10M | 5 |
Kurma Partners
|
— | Detail |
| Jun 16, 2011 | Series A | €2M | 1 |
Ysios Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
8
STAT-Dx is funded by 8 investors.
Gilde Healthcare
and AXIS Telekom
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series C |
AXIS Telekom
|
— | Series C |
Boehringer Ingelheim Venture Fund
|
— | Series C |
Caixa Capital Risc
|
— | Series C |
|
|
— | Series C |
|
Kurma Partners
|
— | Series C |
Next47
|
— | Series C |
|
Ysios Capital
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
